World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
46973
World Ranking
4373
National Ranking
239

Lothar Kanz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lothar Kanz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 972 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lothar Kanz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lothar Kanz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lothar Kanz is affiliated with the University of Tübingen in Germany. Their research spans multiple areas within medicine, with a focus on oncology, hematology, pathology and forensic medicine, pulmonary and respiratory medicine, and immunology.

Their recent publications include the following:

  • Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party, 2020, Haematologica
  • Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation, 2020, Leukemia
  • High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network, 2022, Journal of Clinical Oncology
  • Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer, 2020, Lung Cancer
  • Cooperating, congenital neutropenia-associated Csf3r and Runx1 mutations activate pro-inflammatory signaling and inhibit myeloid differentiation of mouse HSPCs, 2020, Annals of Hematology

The main fields of study in their work are:

  • Medicine

Subfields of study include:

  • Oncology
  • Hematology
  • Pathology and Forensic Medicine
  • Pulmonary and Respiratory Medicine
  • Immunology

The main research topics covered in their publications are:

  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Acute Myeloid Leukemia Research
  • Neutropenia and Cancer Infections
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Blood disorders and treatments

Their work has appeared frequently in publication venues such as:

  • Lung Cancer
  • Annals of Hematology
  • Haematologica
  • Journal of Clinical Oncology
  • Leukemia

Frequent co-authors collaborating with Lothar Kanz include:

  • Linmiao Jiang
  • Catherine Thiéblemont
  • Christiane Pott
  • Gilles Salles
  • Pierre Feugier

Best Publications

  • Retraction: Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids.

    Alexander Kugler;Gernot Stuhler;Peter Walden;Gerhard Zöller

  • Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

    Hermann Einsele;Eddy Roosnek;Nathalie Rufer;Christian Sinzger

  • Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells.

    Peter Brossart;Stefan Wirths;Gernot Stuhler;Volker L. Reichardt

  • Detection and identification of fungal pathogens in blood by using molecular probes.

    H. Einsele;H. Hebart;G. Roller;J. Löffler

  • Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

    Andreas Engert;Heinz Haverkamp;Carsten Kobe;Jana Markova

  • Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia

    Helmut Rainer Salih;Holger Antropius;Friederike Gieseke;Stefan Zoltan Lutz

  • Novel markers for the prospective isolation of human MSC.

    Hans J̈org B̈uhring;Venkata Lokesh Battula;Sabrina Treml;Bernhard Schewe

  • High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

    Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

    Carsten Bokemeyer;Craig R. Nichols;Jean P. Droz;Hans J. Schmoll

  • Identification of HLA-A2–Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies

    Peter Brossart;Kathrin S. Heinrich;Gernot Stuhler;Lars Behnke

  • Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]

    W Brugger;KJ Bross;M Glatt;F Weber

  • Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

    Wolfarm Brugger;Klaus J. Bross;Marria Glatt;Frauke Weber

  • Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.

    Wolfram Brugger;Shelly Heimfeld;Ronald J. Berenson;Roland Mertelsmann

  • Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin

    Wolfram Brugger;Wolfgang Möcklin;Shelly Heimfeld;Ronald J. Berenson

  • Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

    B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben

  • Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia

    Felicitas Thol;Frederik Damm;Andrea Lüdeking;Claudia Winschel

  • Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation.

    Fernando C. Dimeo;Monika H. M. Tilmann;Hartmut Bertz;Lothar Kanz

  • Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1

    Venkata Lokesh Battula;Sabrina Treml;Petra M. Bareiss;Friederike Gieseke

  • Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph^+ALL)

    Barbara Wassmann;Heike Pfeifer;Nicola Goekbuget;Dietrich W. Beelen

Frequent Co-Authors

Hans-Georg Rammensee
Hans-Georg Rammensee University of Tübingen
Peter Brossart
Peter Brossart University Hospital Bonn
Hermann Einsele
Hermann Einsele University of Würzburg
Michael Pfreundschuh
Michael Pfreundschuh Saarland University
Carsten Bokemeyer
Carsten Bokemeyer Universität Hamburg
Stefan Stevanovic
Stefan Stevanovic University of Tübingen
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Rüdiger Hehlmann
Rüdiger Hehlmann Heidelberg University
Holger Hebart
Holger Hebart University of Tübingen
Stefan W. Krause
Stefan W. Krause University of Erlangen-Nuremberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to several rewarding healthcare careers beyond traditional medical school. Some students pursue nursing careers, but wonder, do you have to take a teas test for lpn? Fortunately, many nursing schools now offer flexible options and may not require standard entrance exams, making this path more accessible.

For those interested in the business and management side of healthcare, earning a healthcare administration online degree can provide valuable skills in management, policy, and leadership. These programs are ideal for students aiming to advance quickly in hospital or clinic management roles.

Registered nurses looking to become nurse practitioners can benefit from rn to np bridge programs, which allow for a direct path to advanced clinical practice and greater autonomy. These online routes can be highly flexible and efficient for working professionals.

Lastly, if your passion lies in wellness and dietetics, pursuing a bachelor's in nutrition online can set the foundation for a career in nutrition counseling, public health, or research. Each of these career pathways offers something unique for future healthcare professionals.

Best Scientists Citing Lothar Kanz

Trending Scientists